GENE THERAPY WITH ANGIOGENIC GROWTH FACTORS: A NEW POTENTIAL APPROACH TO THE TREATMENT OF DIABETIC VASCULAR COMPLICATIONS
- 2 Anni 1996/1998
- 92.962€ Totale Fondi
Descrizione non disponibile
Pubblicazioni Scientifiche
- 2002-08-01 AMERICAN JOURNAL OF PATHOLOGY
Sugar-induced modification of fibroblast growth factor 2 reduces its angiogenic activity in vivo
- 2000-02-18 CIRCULATION RESEARCH
Acidosis inhibits endothelial cell apoptosis and function and induces basic fibroblast growth factor and vascular endothelial growth factor expression
- 2000-06-23 CIRCULATION RESEARCH
Nuclear factor-κB and cAMP response element binding protein mediate opposite transcriptional effects on the Flk-1/KDR gene promoter
- 2002-10-04 CIRCULATION RESEARCH
Acidification prevents endothelial cell apoptosis by Axl activation
- 2002-10-01 GENE THERAPY
Adenovirus-mediated VEGF165 gene transfer enhances wound healing by promoting angiogenesis in CD1 diabetic mice
